Diamedica Therapeutics Inc (DMAC)

Feb 25, 2025

DiaMedica Therapeutics Appoints Daniel J. O’Connor to Board - MSN

Feb 25, 2025

Feb 24, 2025

DiaMedica welcomes new board member with biopharma leadershi By Investing.com - Investing.com Nigeria

Feb 24, 2025

Feb 24, 2025

DiaMedica welcomes new board member with biopharma leadershi - Investing.com

Feb 24, 2025

Feb 24, 2025

Can This Biotech Leader Who Turned $40M into $2B Transform DiaMedica Next? - StockTitan

Feb 24, 2025

Feb 21, 2025

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Declines By 8.4% - MarketBeat

Feb 21, 2025

Feb 20, 2025

DiaMedica reports on DM199 stroke treatment mechanism By Investing.com - Investing.com Nigeria

Feb 20, 2025

Feb 20, 2025

DiaMedica reports on DM199 stroke treatment mechanism - Investing.com

Feb 20, 2025

Feb 20, 2025

DiaMedica Therapeutics Announces Publication Of Dm199'S Mechanism Of Action For The Treatment Of Acute Ischemic Stroke In The Journal Stroke - Marketscreener.com

Feb 20, 2025

Feb 20, 2025

Revolutionary Stroke Treatment Mechanism Revealed: How DM199 Could Transform Patient Care - StockTitan

Feb 20, 2025

Feb 13, 2025

Learn to Evaluate (DMAC) using the Charts - Stock Traders Daily

Feb 13, 2025

Feb 10, 2025

DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire

Feb 10, 2025

Feb 05, 2025

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Grows By 14.5% - MarketBeat

Feb 05, 2025

Feb 04, 2025

DiaMedica Therapeutics (NASDAQ:DMAC) Trading Down 1.5%Here's Why - MarketBeat

Feb 04, 2025

Jan 29, 2025

DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke - Seeking Alpha

Jan 29, 2025

Jan 10, 2025

Geode Capital Management LLC Purchases 70,070 Shares of DiaMedica Therapeutics Inc. (NASDAQ:DMAC) - Defense World

Jan 10, 2025

Dec 29, 2024

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$43m - Simply Wall St

Dec 29, 2024

Dec 29, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Short Interest Up 28.4% in December - Defense World

Dec 29, 2024

Dec 20, 2024

Diamedica Stock Soars to 52-Week High, Hits $6.41 - Investing.com

Dec 20, 2024

Dec 19, 2024

Individual investors are DiaMedica Therapeutics Inc.'s (NASDAQ:DMAC) biggest owners and were hit after market cap dropped US$26m - Yahoo Finance

Dec 19, 2024

Dec 15, 2024

Short Interest in DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Declines By 12.2% - MarketBeat

Dec 15, 2024

Dec 12, 2024

Diamedica Stock Soars to 52-Week High, Reaching $5.74 - Investing.com

Dec 12, 2024

Dec 12, 2024

Diamedica Stock Soars to 52-Week High, Reaching $5.74 By Investing.com - Investing.com UK

Dec 12, 2024

Dec 07, 2024

DiaMedica Therapeutics (NASDAQ:DMAC) Trading 0.6% HigherHere's What Happened - MarketBeat

Dec 07, 2024

Dec 07, 2024

DiaMedica Therapeutics (NASDAQ:DMAC) Trading 0.6% Higher – Should You Buy? - Defense World

Dec 07, 2024

Dec 04, 2024

Amneal to Participate at Upcoming Investor Conferences - Business Wire

Dec 04, 2024

Dec 03, 2024

DiaMedica Therapeutics Announces Formation of Scientific Advisor Board to Support the Development of DM199 for the Treatment of Preeclampsia - BioSpace

Dec 03, 2024

Dec 03, 2024

DiaMedica Therapeutics management to meet virtually with Lake Street - Nasdaq

Dec 03, 2024

Dec 03, 2024

DiaMedica Forms Elite Scientific Advisory Board for Preeclampsia Treatment Development - StockTitan

Dec 03, 2024

Dec 02, 2024

Sirius Therapeutics to Present Data from Its Phase 1 Clinical Trial of Factor XI siRNA, a Long-Acting Next-Generation Anticoagulant for Thromboembolic Disorders at the 66th ASH Annual Meeting and Exposition - Business Wire

Dec 02, 2024

Nov 26, 2024

DMAC Stock Soars to 52-Week High, Hits $4.95 Amid Bullish Run - Investing.com

Nov 26, 2024

Nov 23, 2024

Here's Why We're Not Too Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Situation - Simply Wall St

Nov 23, 2024

Nov 16, 2024

We're Not Very Worried About DiaMedica Therapeutics' (NASDAQ:DMAC) Cash Burn Rate - Yahoo Finance

Nov 16, 2024

Nov 15, 2024

HC Wainwright Reaffirms Buy Rating for DiaMedica Therapeutics (NASDAQ:DMAC) - MarketBeat

Nov 15, 2024

Nov 15, 2024

DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 15, 2024

Nov 14, 2024

DiaMedica Therapeutics Reports Q3 2024 Financial Results - TipRanks

Nov 14, 2024

Nov 14, 2024

DMACDiaMedica Therapeutics Inc. Latest Stock News & Market Updates - StockTitan

Nov 14, 2024

Nov 14, 2024

DiaMedica Therapeutics Announces Dosing of First Patient in Phase 2 Trial of DM199 in the Treatment of Preeclampsia - BioSpace

Nov 14, 2024

Nov 14, 2024

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2024 Financial Results - BioSpace

Nov 14, 2024

Nov 12, 2024

DiaMedica (DMAC) to Present at Craig-Hallum Conference: Spotlight on DM199 Stroke Treatment | DMAC Stock News - StockTitan

Nov 12, 2024

Nov 12, 2024

DiaMedica Therapeutics to Participate in Upcoming Craig-Hallum 15th Annual Alpha Select Conference - Yahoo Finance

Nov 12, 2024

Nov 07, 2024

DiaMedica Therapeutics (DMAC) Set to Announce Quarterly Earnings on Wednesday - MarketBeat

Nov 07, 2024

Nov 07, 2024

CRH plc (the "Company") Form 10-Q for the quarterly period ended September 30, 2024 - Business Wire

Nov 07, 2024

Nov 06, 2024

DiaMedica Therapeutics to Provide a Business Update and Report Third Quarter 2024 Financial Results November 14, 2024 - BioSpace

Nov 06, 2024